Logo

macular degeneration

Genosity Inks Deal With Gemini Therapeutics to Develop Assay for AMD Clinical Trial Patient Selection

The assay will be used to select patients for enrollment in a Phase IIa study of Gemini Therapeutics' dry age-related macular degeneration drug GEM103.

Homomorphic Encryption Might Hold Key to Fast, Large-Scale GWAS
Premium

Researchers from startup Duality Technologies and Dana-Farber have demonstrated the efficacy and speed of a highly secure technique for analyzing encrypted genomic data.

Age-Related Macular Degeneration Genes Revealed in Transcriptome Studies

A team led by National Eye Institute researchers picked out B3GLCT and BLOC1S1 as the most plausible target genes in an age-related macular degeneration analysis.

Inherited Retinal Disease Patients, Therapy Developers May Benefit From New Genetic Testing Program
Premium

To study the benefit of genetic testing data, the Foundation Fighting Blindness offered free clinical testing to 100 members of its My Retina Tracker patient registry.

International Consortium IDs New Loci Linked to Age-Related Macular Degeneration

The International AMD Genomics Consortium has uncovered 34 AMD-associated loci, including a site with specific ties to the wet AMD subtype.

Sep 16, 2015

Studies Confirm Interaction of Genetics, Diet, Exercise Affect Age-Related Macular Degeneration Risk

Nov 26, 2014

OliX Licenses AMD Drug to YuYu Pharma
Premium

Nov 25, 2014

Benitec Provides Update on HCV, Earlier-stage Pipeline Programs
Premium

Oct 27, 2014

NEI Awards Cellular Dynamics $1.2M Contract for iPSCs for Development of AMD Drug

Jul 7, 2014

AMD Insight Licenses ArcticDx's Age-related Macular Degeneration MDx Test

Jan 16, 2014

Nicox to Market Sequenom's RetnaGene AMD Test in North America

Oct 24, 2013

Scripps Team Shows Potential of microRNA Knockdown for Ocular Diseases
Premium

Sep 16, 2013

Rare Variant Studies Underscore Immune Pathway Role in Age-related Macular Degeneration

Jul 18, 2013

RXi Releases Phase I Data on Anti-Scarring Drug, Aims for Phase II This Year
Premium

Jun 13, 2013

After Acquiring Opko Assets, RXi Aims to Resurrect Former Phase III AMD Drug
Premium

Apr 4, 2013

Washington University Team Reports on Link Between microRNA-33 and AMD
Premium

Mar 4, 2013

GWAS Meta-analysis Reveals 19 Loci Linked to Age-related Macular Degeneration Risk

Nov 9, 2012

Sequenom, ArcticDx Settle IP Litigation

Mar 22, 2012

Silence Says Cash Runway Ends in Q3, Directors Have 'Uncertainty' About Additional Fundraising
Premium

Mar 1, 2012

Canadian MDx Firm ArcticDx Takes Sequenom to Court over Patent Fight

May 17, 2011

Renaming its Genome Center, Wash U Expands Focus to Clinical Applications of Sequencing
Premium

Mar 24, 2011

Quark, Pfizer Amend Deal for Ocular Disease Drug on Less-than-Ideal Phase II Data
Premium

Feb 10, 2011

Q&A: Univeristy of Kentucky's Jayakrishna Ambati on a Role for Dicer in AMD
Premium

Nov 12, 2010

ArcticDx Comes to US, Eyes FDA Approval for AMD Test

Feb 9, 2010

Sequenom Licenses Rights to Macular Degeneration Genetic Test

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.